Cancer-associated fibroblast subtype signature gene predicts survival and immunotherapy response in sarcoma
Ji-Yong Sung, Jin-Hong Kim, Yi-Jun Kim · 2026
Read Cancer-associated fibroblast subtype signature gene predicts survival and immunotherapy response in sarcoma by Ji-Yong Sung, Jin-Hong Kim, Yi-Jun Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353369.txt.
Description
Ji-Yong Sung, Jin-Hong Kim, and Yi-Jun Kim search the neighbourhood around sarcoma tumours for clues to immunotherapy success, in this 2026 PLOS ONE study. Sarcomas respond unevenly to immune-checkpoint drugs, and the fibroblast cells surrounding a tumour help decide who benefits. Using single-cell data from two patient groups plus tumour records for hundreds more, they sorted fibroblasts into three subtypes.
Gene signatures from the subtypes tracked with predicted drug response, but differently across sarcoma kinds. One small four-gene signature, active in the inflammatory subtype, stood out as a candidate for forecasting survival. The authors stress it is a lead for testing, not yet a clinical tool.
Catalog record
| CREATOR | Ji-Yong Sung, Jin-Hong Kim, Yi-Jun Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39866 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |